Prostate Cancer Diagnoses Decrease With Lenient Screening Recommendations
After the USPSTF advised against prostate cancer screening for all men, there was a decrease in the incidence of the disease.
After the United States Preventative Services Task Force (USPSTF) recommended against all men being screened for prostate cancer, there was a decrease in the incidence around the nation, according to MaryBeth Freeman, MPH, senior associate scientist at the American Cancer Society.
Freeman also emphasized that the USPSTF updated their guidelines again in 2018 to state that men should have thorough discussions with their healthcare providers about the risks and benefits of prostate cancer screening, as it pertains to them individually. This will prevent over-screening in this population, while also ensuring that men who may be at risk for the disease are still getting the appropriate screening and potential diagnosis.
Pembrolizumab Plus Enzalutamide and ADT Falls Short in mHSPC
November 26th 2023Pembrolizumab, in addition to enzalutamide and androgen deprivation therapy, was not associated with better radiographic progression-free survival outcomes in patients with metastatic hormone-sensitive prostate cancer.
Key Advances in Cancer Survivorship Toxicity Management
July 15th 2022In this episode of The Vitals, Lidia Schapira, MD, FASCO, recounts highlights from the 2022 ASCO Symptoms and Survivorship track and underscores key takeaways for practitioners seeking to enhance the delivery of cancer survivorship care.
